title: Autoimmune thrombocytopenia after treatment with Campath 1H in a patient with chronic lymphocytic leukaemia.
authors.forename: S H
authors.initials: SH
authors.lastname: Otton
authors.forename: D L
authors.initials: DL
authors.lastname: Turner
authors.forename: R
authors.initials: R
authors.lastname: Frewin
authors.forename: S V
authors.initials: SV
authors.lastname: Davies
authors.forename: S A
authors.initials: SA
authors.lastname: Johnson
mesh_terms: D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000009:adverse effects*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000209:etiology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000074323:Alemtuzumab